Episode

Big Tech on Deck, Musk vs. OpenAI, and Cardiac Drug Breakthroughs 4/27/26

Podcast: The Exchange
Published: Apr 27, 2026
Duration seconds: 2652
Processing state: not_requested
Canonical source: https://www.cnbc.com
Audio: https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/6238655f-ae42-419d-a14c-edccbf577d8e/episodes/2c7aee06-23f3-44eb-a5d9-aceaee336ef4/audio/128/default.mp3?aid=rss_feed&awCollectionId=6238655f-ae42-419d-a14c-edccbf577d8e&awEpisodeId=2c7aee06-23f3-44eb-a5d9-aceaee336ef4&feed=tc4zxWgX
JSON: /v1/public/podcasts/the-exchange-431205/episodes/big-tech-on-deck-musk-vs-openai-and-cardiac-drug-breakthroughs-4-27-26
Markdown: /podcast/the-exchange-431205/big-tech-on-deck-musk-vs-openai-and-cardiac-drug-breakthroughs-4-27-26.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-exchange-431205/episodes/big-tech-on-deck-musk-vs-openai-and-cardiac-drug-breakthroughs-4-27-26/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-exchange-431205/big-tech-on-deck-musk-vs-openai-and-cardiac-drug-breakthroughs-4-27-26.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

With five of the Mag 7 reporting this week, we discuss whether investors should temper their capex expectations. The trial between Elon Musk and Sam Altman kicks off. Plus, the potential next frontier in preventing heart attacks.